New Device Reduces Risk of Stroke in Patients with Atrial Fibrillation
Links shared publicly online about this topic.
- 953total visits
New Device Reduces Risk of Stroke in Patients with Atrial Fibrillation
View full resource at hcplive.com
Tags: Heart Disease, Atrial Fibrillation, Stroke, Thrombotic Event, Drug, Anti-Clotting Medication, Anticoagulant
Most Recently Shared on August 12, 2010 at 2:05 pm By:
Device reduces stroke risk and eliminates need for anticoagulant medications in patients with atrial fibrillation http://hcp.lv/97W4hM
Pradaxa and Eliquis gain trial boost over warfarin | InPharm
inpharm.com — “Two new blood thinners are superior to warfarin at reducing the risk of stroke in atrial fibrillation (AF) patients” View full resource at inpharm.com
Most Recently Shared on August 31, 2011 at 10:05 am By:
Pharmafocus Pharma and Health News
Pradaxa and Eliquis gain trial boost over warfarin http://ow.ly/6hpDN #pharma
New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation - Health News - redOrbit
redorbit.com — “RIDGEFIELD, Conn., April 4, 2011 /PRNewswire/ -- Two new retrospective subanalyses of the RE-LY(R) trial, involving Pradaxa(R) (dabigatran etexilate mesylate) capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin (1) occurred irrespective of CHA2DS2-VASc risk score (2) and the type of non-valvular atrial fibrillation (NVAF) (permanent, persistent and paroxysmal)(3).” View full resource at redorbit.com
Most Recently Shared on April 4, 2011 at 5:52 pm By:
New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scor... http://bit.ly/dH9RNZ
PRADAXA (dabigatran etexilate) - Reducing Risk of Stroke from Atrial Fibrillation (AFib)
pradaxapro.com — “Learn more about PRADAXA Atrial Fibrillation treatment for reducing the risk of stroke. Side effects may occur. PRADAXA (dabigatran etexilate mesylate) capsules is a direct thrombin inhibitor indicated to reduce the risk of stroke in patients who have atrial fibrillation. Please see Important Safety Information.” View full resource at pradaxapro.com
Most Recently Shared on March 16, 2011 at 8:54 pm By:
Terri Schmitt Nurse and Advanced Practice Nurse
RT @ERnursegirl: Pradaxa- new medication being used instead of coumadin and doesn't require frequent labs like coumadin. http://ow.ly/4fkcG
Experimental agent better than aspirin at preventing stroke in some atrial fibrillation patients - News - Virtual Medical Centre
virtualmedicalcentre.com — “A new anti-clotting agent is vastly superior to aspirin at reducing stroke risk (1.6 per cent per year versus 3.6 per cent per year) in atrial fibrillation (AF) patients unable to take stronger drugs.” View full resource at virtualmedicalcentre.com
Most Recently Shared on February 27, 2011 at 1:14 pm By:
VirtualMedicalCentre Health Site
Experimental agent better than aspirin at preventing stroke in some atrial fibrillation patients http://dlvr.it/HlZvz #Healthnews
Final Data Shows Experimental Agent Better Than Aspirin At Preventing Stroke In Some Atrial Fibrillation Patients
medicalnewstoday.com — “A new anti-clotting agent is vastly superior to aspirin at reducing stroke risk (1.6 percent per year versus 3.6 percent per year) in atrial fibrillation (AF) patients unable to take stronger drug” View full resource at medicalnewstoday.com
Most Recently Shared on February 11, 2011 at 3:25 pm By:
MedicalNewsToday: Final Data Shows Experimental Agent Better Than Aspirin At Preventing: http://bit.ly/dVLYXt Full http://bit.ly/eCZJ3Y
Final data show experimental agent better than aspirin at preventing stroke | e! Science News
esciencenews.com — “A new anti-clotting agent is vastly superior to aspirin at reducing stroke risk (1.6 percent per year versus 3.6 percent per year) in atrial fibrillation (AF) patients unable to take stronger drugs, according to final data reported today at the American Stroke Association's International Stroke Conference 2011. Researchers found the drug also works better in people with a history of stroke or a warning stroke.” View full resource at esciencenews.com
Most Recently Shared on February 11, 2011 at 2:09 am By:
Final data show experimental agent better than aspirin at preventing stroke http://bit.ly/e1hivn
Strict heart rate control provides no advantage over lenient approach, study finds
sciencedaily.com — “Strict heart rate control in atrial fibrillation patients is not beneficial over lenient control, according to new research. The antiplatelet drug clopidogrel, plus aspirin, might be considered to reduce the risk of major vascular events, including stroke in patients who are poor candidates for the anticoagulant drug warfarin. Catheter ablation is useful to maintain normal sinus rhythm in patients with atrial fibrillation.” View full resource at sciencedaily.com
Most Recently Shared on December 31, 2010 at 10:57 pm By:
Strict heart rate control provides no advantage over lenient approach, study finds: Strict heart rate control in... http://bit.ly/hUcQK4
Strict heart rate control provides no advantage over lenient approach, study finds
sciencedaily.com — “Strict heart rate control in atrial fibrillation patients is not beneficial over lenient control, according to new research. The antiplatelet drug clopidogrel, plus aspirin, might be considered to reduce the risk of major vascular events, including stroke in patients who are poor candidates for the anticoagulant drug warfarin. Catheter ablation is useful to maintain normal sinus rhythm in patients with atrial fibrillation.” View full resource at sciencedaily.com
Most Recently Shared on December 31, 2010 at 3:20 am By:
Strict heart rate control provides no advantage over lenient approach, study finds http://bit.ly/gsXxma
Strict heart rate control provides no advantage over lenient approach, study finds
sciencedaily.com — “Strict heart rate control in atrial fibrillation patients is not beneficial over lenient control, according to new research. The antiplatelet drug clopidogrel, plus aspirin, might be considered to reduce the risk of major vascular events, including stroke in patients who are poor candidates for the anticoagulant drug warfarin. Catheter ablation is useful to maintain normal sinus rhythm in patients with atrial fibrillation.” View full resource at sciencedaily.com
Most Recently Shared on December 21, 2010 at 2:26 am By:
ScienceDaily: Strict heart rate control provides no advantage over lenient approach, study http://bit.ly/eRfhR5 Full http://bit.ly/eg7wAP
ksl.com - New heart implant targets risk for stroke
ksl.com — “Salt Lake medical inventor Coherex Medical just performed the world's first operation with a closure device for the left atrial appendage. The company aims to prove it will greatly reduce the risk of stroke in patients with atrial fibrillation.” View full resource at ksl.com
Most Recently Shared on October 30, 2010 at 12:39 pm By:
Tammi Jacobs Health Professional
ksl.com - New heart implant targets risk for stroke http://bit.ly/bXl67p
Study shows early diagnosis of atrial fibrillation reduces risk of stroke
news-medical.net — “The earlier that patients who suffer from atrial fibrillation obtain the correct treatment, the lower is the risk of serious secondary effects such as stroke. A thesis presented at the University of Gothenburg, Sweden, shows that a well-established measurement score can easily assess the risks for this patient group.” View full resource at news-medical.net
Most Recently Shared on August 16, 2010 at 10:59 am By:
Stroke News: Study shows early diagnosis of atrial fibrillation reduces risk of stroke: The earlier that patient... http://twurl.nl/s51o5n
Dabigatran Etexilate Shows Greater Reductions Than Warfarin in Stroke in Patients with Atrial Fibrillation across All Stroke Risk Groups | EON: Enhanced Online News
feeds.businesswire.com — “INGELHEIM, Germany--(EON: Enhanced Online News)--Data presented today at the 59th Annual Scientific Session of the American College of Cardiology have shown greater reductions in stroke in patients with atrial fibrillation (AF) for dabigatran etexilate* compared to the current standard of care, warfarin, irrespective of a patient’s risk profile for stroke.1 The new sub-group analysis from the landmark RE-LY® study** assessed the rate of stroke and systemic embolism in patients defined ” View full resource at feeds.businesswire.com
Most Recently Shared on March 15, 2010 at 4:10 pm By:
Dabigatran (Coumadin-repl) reduces strokes more than warfarin in atrial fibrillation patients: http://bit.ly/be8sd1 @EON_Health #ACC10 #afib
Oral dabigatran etexilate reduces the risk of stroke and systemic embolism
news-medical.net — “Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation c” View full resource at news-medical.net
Most Recently Shared on August 31, 2009 at 6:55 am By:
Stroke News: Oral dabigatran etexilate reduces the risk of stroke and systemic embolism: Boehringer .. http://twurl.nl/5ybh0q
Aspirin With Plavix Reduced Stroke Risk, Study
medicalnewstoday.com — “A large new study found that taking aspirin with clot busting drug Plavix (clopidogrel) cut the risk of stroke by 28 per cent in patients with irregular heart rhythms (atrial fibrillation) who w” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2009 at 6:22 pm By:
John L LeRoy Jr MD Plastic Surgeon, Physician, Doctor, and Surgeon
http://bit.ly/4EdjZ Aspirin With Plavix Reduced Stroke Risk, Study
Advertisement
